Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 07/19 09:07:09 pm
92.14 EUR   -0.88%
07/12Lanxess water treatment unit attracts interest - sources
RE
07/11BAYER : Still trending down
07/10BAYER : U.S. judge allows lawsuits over Monsanto's Roundup to procee..
RE
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Bayer : Shareholder Temasek Agrees to Increase Share Capital

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2018 | 07:29am CEST

By Anthony Shevlin

Bayer said late Monday that investment company Temasek has signed an agreement to increase its share capital in the German company.

Temasek has subscribed to 31 million new Bayer shares, which equals around 3.6 percent of Bayer's capital stock, for 3 billion euros ($3.71 billion) in total gross proceeds, Bayer said.

Under the agreement, Bayer will issue the new registered--no par value--shares to a subsidiary of Temasek at market prices with an entitlement to dividends as of Jan. 1, 2017, the German company said.

Once the capital increase has been completed, and together with its existing shareholdings, Temasek will hold approximately 4 percent of Bayer's issued capital stock, Bayer said. The issued shares won't be subject to any lock-up period, it said.

Bayer Chief Executive Werner Baumann said the "investment affirms our business strategy including the proposed acquisition of Monsanto], as well as Bayer's strong growth prospects."

Write to Anthony Shevlin at [email protected]

Stocks mentioned in the article
ChangeLast1st jan.
BAYER -0.66% 92.35 Delayed Quote.-9.17%
MONSANTO 0.00%-End-of-day quote.9.57%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
07/12BAYER : Findings from Bayer in the Area of Medical Statistics Described (A Bayes..
AQ
07/12Lanxess water treatment unit attracts interest - sources
RE
07/10BAYER : U.S. judge allows lawsuits over Monsanto's Roundup to proceed to trial
RE
07/06BAYER : expands strategic alliance with Broad Institute of MIT and Harvard
AQ
07/06BAYER : Greenberg Traurig Advised Tecnoquimicas on Acquisition of MK Generics Bu..
AQ
07/05BAYER : Findings from Bayer Reveals New Findings on Personalized Medicine (Recen..
AQ
07/04Thyssenkrupp, Tata Steel may need asset sales to get EU nod for JV
RE
07/04BAYER : Animal Health and Mitsui Chemicals Agro sign global license agreement
PU
07/03Bayer sees Brazil as key growth driver for global crop division
RE
06/30BAYER : Broad and Bayer Expand Partnership, Launching New Research Effort to Dev..
AQ
More news
News from SeekingAlpha
07/123 THINGS IN BIOTECH, JULY 12 : Immunotherapy Brawl, And A Creeper In The Weeds 
07/10Judge says lawsuits alleging Roundup weedkiller causes cancer can go to trial 
07/05Bayer Animal Health in-licenses IP from Mitsui Chemicals Agro for parasiticid.. 
07/03YOUR DAILY PHARMA SCOOP : Redhill's New Patent, Nuvectra Slips, Teligent Gains 
07/03U.S. CORPORATE BOND MARKET BRACES FO : Bloomberg 
Financials (€)
Sales 2018 39 172 M
EBIT 2018 7 777 M
Net income 2018 4 973 M
Debt 2018 33 269 M
Yield 2018 2,98%
P/E ratio 2018 18,79
P/E ratio 2019 16,71
EV / Sales 2018 3,08x
EV / Sales 2019 2,56x
Capitalization 87 484 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 116 €
Spread / Average Target 24%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-9.17%101 370
JOHNSON & JOHNSON-7.59%346 292
PFIZER3.95%220 236
ROCHE HOLDING LTD.-4.77%200 995
NOVARTIS-2.11%200 139
MERCK AND COMPANY11.85%168 225